Resource Hub
Replacing Legacy Systems at Scale: Bayer’s Global Migration to the CARA Platform
85,000 Users 900,000 Documents Documentum Replacement A global upgrade involving almost million regulatory documents, streamlined infrastructure, and a strategic move from Documentum to the modern, cloud-based CARA platform. Read the Case Study
Protected: Generis Celebrates New Milestone: Egyptian Drug Authority Chooses EXTEDOpulse Powered by CARA
There is no excerpt because this is a protected post.
Bridging the Gap: AI for Life Sciences Without Compromising Compliance
Generic AI tools can’t handle pharma’s reality. They don’t guarantee audit trails. They fragment your validated systems. They create regulatory risks faster than they solve operational problems. But here’s what’s also true: teams that figure out compliant AI deployment will dominate the next decade. CARA AI solves the problem everyone
Global Pharma Modernises Archiving with CARA Platform
13 Terabytes of content across two repositories 65 Million documents and records requiring migration Ongoing archive requests continuing during migration A global pharmaceutical company needed to modernise its document archiving infrastructure to reduce costs, eliminate system redundancy, and meet evolving regulatory requirements. Read the Case Study
Merck: Consolidating 12 Siloed Solutions to a Single Platform with CARA.
85,000 Users 12 Systems Consolidated 18 Million Documents Merck, the oldest pharmaceutical company in the world, implement the CARA Life Sciences Platform to consolidate and unify multiple siloed systems across Quality, Regulatory, Safety, and Clinical (eTMF) processes. Read the Case Study
From Months to Minutes: Can AI Really Transform Regulatory Submissions?
From Months to Minutes: Can AI Really Transform Regulatory Submissions? For regulatory professionals, the idea of cutting hundreds of hours of painstaking work down to just a few clicks has always felt out of reach. Imagine Module 2 and Module 3 documents generated directly from data. Product labels compared across
Immunic Therapeutics Selects CARA Life Sciences Platform to Streamline Regulatory Operations and Accelerate Submissions
Immunic Therapeutics Selects CARA Life Sciences Platform to Streamline Regulatory Operations and Accelerate Submissions CARA Life Sciences Platform Adoption Continues to Grow with Biotech Organisation Immunic Therapeutics Generis, the creator of the CARA Life Sciences Platform, today announced that Immunic, a fast-growing biotechnology company focused on treatments for immunologic diseases,
CARA Platform Migration Guide with DAQUMA
We know that migrating from complex, entrenched legacy systems can be daunting – especially when you’re managing large volumes of data and critical processes. That’s why we’ve teamed up with our trusted migration partners at DAQUMA to create a short migration guide for the CARA Platform. This high-level guide unpacks
